First‐in‐class pyrido[2,3‐ <i>d</i> ]pyrimidine‐2,4(1 <i>H</i> ,3 <i>H</i> )‐diones against leishmaniasis and tuberculosis: Rationale, in vitro, ex vivo studies and mechanistic insights-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

First‐in‐class pyrido[2,3‐ d ]pyrimidine‐2,4(1 H ,3 H )‐diones against leishmaniasis and tuberculosis: Rationale, in vitro, ex vivo studies and mechanistic insights

Published:2022-02 Issue:4 Volume:355 Page:2100440
ISSN:0365-6233
Container-title:Archiv der Pharmazie
language:en
Short-container-title:Archiv der Pharmazie

Author:

Ramesh Deepthi¹,Sarkar Deblina²,Joji Annu¹,Singh Monica³,Mohanty Amaresh K.⁴,G. Vijayakumar Balaji¹,Chatterjee Mitali²,Sriram Dharmarajan³,Muthuvel Suresh K.⁴,Kannan Tharanikkarasu¹^ORCID

Affiliation:

1. Department of Chemistry Pondicherry University Kalapet Puducherry India

2. Department of Pharmacology Institute of Post Graduate Medical Education & Research (IPGME&R) Kolkata West Bengal India

3. Department of Pharmacy Birla Institute of Technology & Science Pilani Hyderabad India

4. Department of Bioinformatics Pondicherry University Kalapet Puducherry India

Funder

University Grants Commission

Indian Council of Medical Research

Publisher

Wiley

Subject

Drug Discovery,Pharmaceutical Science

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ardp.202100440

Reference97 articles.

1. World Health Organisation Leishmaniasis fact sheet Vol. 2020 2020.https://www.who.int/news-room/fact-sheets/detail/leishmaniasis

2. Dihydropyrido[2,3-d]pyrimidines as a new class of antileishmanial agents

3. Design, synthesis and biological evaluation of aryl pyrimidine derivatives as potential leishmanicidal agents

4. Insights into the current status of privileged N-heterocycles as antileishmanial agents

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Challenging the Biginelli scaffold to surpass the first line antitubercular drugs: Mycobacterium tuberculosis thymidine monophosphate kinase (TMPK mt ) inhibition activity and molecular modelling studies;Journal of Enzyme Inhibition and Medicinal Chemistry;2024-09-11

2. Description of Some Methodologies for the Synthesis of 1,4-Naphthoquinone Derivatives and Examples of their Biological Activity: A Review;Current Organic Chemistry;2024-07

3. Novel pyrimidine – Imines against tuberculosis: Rationale, in vitro, in silico studies and mechanistic insights;Journal of Molecular Structure;2023-11

4. Synthesis of Pyrido[2,3-d]pyrimidines Catalyzed by 2,3-Dichloro-5,6-dicyano-1,4-benzoquinone (DDQ)/tert-Butyl Nitrite (TBN)/O2;Synthesis;2023-08-18

5. Synthesis, antitubercular evaluation, and molecular docking studies of hybrid pyridinium salts derived from isoniazid;Drug Development Research;2023-02-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3